These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22792384)

  • 1. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection.
    Arnold EA; Hazelton P; Lane T; Christopoulos KA; Galindo GR; Steward WT; Morin SF
    PLoS One; 2012; 7(7):e40603. PubMed ID: 22792384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexposure Prophylaxis for Prevention of HIV Acquisition Among Adolescents: Clinical Considerations, 2020.
    Tanner MR; Miele P; Carter W; Valentine SS; Dunville R; Kapogiannis BG; Smith DK
    MMWR Recomm Rep; 2020 Apr; 69(3):1-12. PubMed ID: 32324724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.
    Liu AY; Cohen SE; Vittinghoff E; Anderson PL; Doblecki-Lewis S; Bacon O; Chege W; Postle BS; Matheson T; Amico KR; Liegler T; Rawlings MK; Trainor N; Blue RW; Estrada Y; Coleman ME; Cardenas G; Feaster DJ; Grant R; Philip SS; Elion R; Buchbinder S; Kolber MA
    JAMA Intern Med; 2016 Jan; 176(1):75-84. PubMed ID: 26571482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP.
    Blumenthal J; Jain S; Krakower D; Sun X; Young J; Mayer K; Haubrich R;
    AIDS Behav; 2015 May; 19(5):802-10. PubMed ID: 25616837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
    Adams LM; Balderson BH
    AIDS Care; 2016 Sep; 28(9):1154-8. PubMed ID: 26915281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG; Landovitz RJ; Kapogiannis B; Siberry GK; Rudy B; Rutledge B; Liu N; Harris DR; Mulligan K; Zimet G; Mayer KH; Anderson P; Kiser JJ; Lally M; Brothers J; Bojan K; Rooney J; Wilson CM
    JAMA Pediatr; 2017 Nov; 171(11):1063-1071. PubMed ID: 28873128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putting PrEP into Practice: Lessons Learned from Early-Adopting U.S. Providers' Firsthand Experiences Providing HIV Pre-Exposure Prophylaxis and Associated Care.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Gaston Hawkins LA; Hansen NB; Kershaw TS; Underhill K; Betancourt JR; Dovidio JF
    PLoS One; 2016; 11(6):e0157324. PubMed ID: 27304883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California.
    Landovitz RJ; Beymer M; Kofron R; Amico KR; Psaros C; Bushman L; Anderson PL; Flynn R; Lee DP; Bolan RK; Jordan WC; Tseng CH; Dierst-Davies R; Rooney J; Wohl AR
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):501-511. PubMed ID: 28902074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Support Your Client at the Space That They're in": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation.
    Calabrese SK; Magnus M; Mayer KH; Krakower DS; Eldahan AI; Hawkins LAG; Underhill K; Hansen NB; Kershaw TS; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2017 Apr; 31(4):196-204. PubMed ID: 28414261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.
    Krakower D; Ware N; Mitty JA; Maloney K; Mayer KH
    AIDS Behav; 2014 Sep; 18(9):1712-21. PubMed ID: 24965676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing Experiences with Pre-Exposure Prophylaxis in Boston Among Lesbian, Gay, Bisexual, and Transgender Specialists and Generalists in Primary Care: Implications for Scale-Up.
    Krakower DS; Ware NC; Maloney KM; Wilson IB; Wong JB; Mayer KH
    AIDS Patient Care STDS; 2017 Jul; 31(7):297-304. PubMed ID: 28574774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding HIV Pre-Exposure Prophylaxis Questions of U.S. Health Care Providers: Unique Perspectives from the PrEPline Clinical Teleconsultation Service.
    Saberi P; Mehtani NJ; Sayegh A; Camp CE; Chu C
    Telemed J E Health; 2023 Mar; 29(3):376-383. PubMed ID: 35802493
    [No Abstract]   [Full Text] [Related]  

  • 17. Health Care Provider Perspectives on Pre-exposure Prophylaxis: A Qualitative Study.
    Przybyla S; LaValley S; St Vil N
    J Assoc Nurses AIDS Care; 2019; 30(6):630-638. PubMed ID: 30958406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
    Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
    Mayer KH; Agwu A; Malebranche D
    Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-Exposure Prophylaxis (PrEP) for Safer Conception Among Serodifferent Couples: Findings from Healthcare Providers Serving Patients with HIV in Seven US Cities.
    Finocchario-Kessler S; Champassak S; Hoyt MJ; Short W; Chakraborty R; Weber S; Levison J; Phillips J; Storm D; Anderson J
    AIDS Patient Care STDS; 2016 Mar; 30(3):125-33. PubMed ID: 26824425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.